Reducing Opioid Misuse: Evaluation of a Medicaid Controlled Substance Lock-In Program

Area of Science:

• Public Health
• Health Policy
• Pharmacoeconomics

Background:

• Opioid misuse, abuse, and overdose represent a critical public health crisis.
• Medicaid Lock-In Programs (MLIPs) are implemented to curb overutilization of controlled substances among Medicaid beneficiaries.
• Limited data exists on the real-world impact of MLIPs on patient prescribing patterns and healthcare expenditures.

Purpose of the Study:

• To evaluate the effect of North Carolina's MLIP on Medicaid-reimbursed opioid prescriptions.
• To analyze changes in opioid utilization metrics, including claims, pharmacy use, supply duration, units, and costs, following MLIP enrollment.
• To assess the efficacy of MLIPs as a strategy to mitigate the opioid epidemic.

Main Methods:

• Utilized North Carolina Medicaid claims data spanning October 2008 to June 2013.
• Employed mixed-effects models to analyze the impact of MLIP enrollment on monthly opioid-related outcomes.
• Examined data for 6,148 patients enrolled in the MLIP.

Main Results:

• MLIP enrollment was associated with an 84% reduction in the odds of having any opioid claim per month (OR = 0.16).
• Significant decreases observed in monthly opioid prescriptions (-1.13), number of pharmacies used (-0.61), and Medicaid expenditures for opioids (-$22.78).
• The program demonstrated a substantial impact on reducing opioid prescription frequency and associated costs.

Conclusions:

• MLIPs appear to be a successful component in comprehensive strategies to reduce potential opioid overutilization.
• The findings suggest MLIPs can effectively decrease prescription opioid misuse, abuse, and diversion.
• Further research is warranted to investigate potential unintended consequences and ensure patient access to necessary pain management.